ABOUT THIS EPISODE
Jonathan Gillard, discusses morphology and risk, cellular function in drug studies and contrast agents, and the importance of biomechanical processes in studies of AAA using MRI technology. (September 5, 2008)
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of Abdominal Aortic Aneurysm Summit.
OTHER EPISODES IN THIS PODCAST
B. Timothy Baxter, MD, discusses different studies on chemical treatments that have been shown to effect AAA behavior. (September 4, 2008)
Charles A. Taylor and Ronald L. Dalman give thanks to all presenters and people involved in the summit and call for future collaboration to better each individual's research results. (September 5, 2008)
David Vorp discusses methods of predicting AAA rupture non-invasively, that is patient specific rather than based solely upon aneurysm diameter. (September 5, 2008)
Susan Lindquist, Professor of Biology at the Massachusetts Institute of Technology (MIT), and Member of the Whitehead Institute for Biomedical Research, delivers the 12th Annual Dorfman Memorial Lecture. (December 15, 2009)
Geoffrey Rubin, MD, discusses the pros and cons of different types of imaging systems available for monitoring AAA progress. (September 5, 2008)
Disclaimer: The podcast and artwork embedded on this page are from Stanford University, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
